Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 6c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.59), $0.06 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $0 versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
• BMO starts chip stocks coverage: Here are its preferred picks